Evidence map›Paper›PMID 41044334›Full record

ArticleScientific reports2025

LncRNA RMRP knockdown upregulates PD-1 expression in natural killer cells.

Sarah Abouhegaziah, Doris Urlaub, Ahmed Moustafa, Maha Mostafa, Amged Ouf, Khaled Abou-Aisha, Carsten Watzl, Mona Rady

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sarah AbouhegaziahMicrobiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo, Cairo, Egypt.
Doris UrlaubLeibniz Research Centre for Working Environment and Human Factors (IfADo), TU Dortmund, Dortmund, Germany.
Ahmed MoustafaDepartment of Biology, American University in Cairo, New Cairo, Egypt.
Maha MostafaMicrobiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo, Cairo, Egypt.
Amged OufDepartment of Biology, American University in Cairo, New Cairo, Egypt.
Khaled Abou-AishaMicrobiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo, Cairo, Egypt.
Carsten WatzlLeibniz Research Centre for Working Environment and Human Factors (IfADo), TU Dortmund, Dortmund, Germany.
Mona RadyMicrobiology, Immunology and Biotechnology Department, Faculty of Pharmacy and Biotechnology, The German University in Cairo, Cairo, Egypt. mona.rady@guc.edu.eg.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of long non-coding RNAs (lncRNAs) in Natural Killer (NK) cells is still an ongoing research question. LncRNAs are RNAs with a length of more than 200 nucleotides. While they do not code for functional proteins, they have many regulatory roles from transcriptional to post-translational mechanisms that can affect gene expression. On the other hand, NK cells are large, innate, granular immune cells that exert cytotoxic effects against virus-infected and malignant cells using various mechanisms of actions. In this study, we aimed to perform functional analysis of lncRNAs in NK cells. We focused on five lncRNAs: MALAT1, RMRP, LINC-PINT, GAS5, and LINC00299. Our findings revealed that the expressions of the five lncRNAs were downregulated in cultured NK cells and upon cytokine stimulation. In addition, we observed an upregulation of the PD-1 receptor on the surface of NK cells in response to knocking down RMRP. This suggests that RMRP may have an inhibitory effect on PD-1 expression in NK cells. The proposed inverse relationship between RMRP and PD-1 offers new insights into the regulation of PD-1 expression and its role in NK cell function. Given PD-1's critical role as an immune checkpoint, by understanding the regulatory relationship between RMRP and PD-1, new strategies can be explored to enhance NK cell efficacy, opening up new possibilities for designing immunotherapies that restore NK cell function by potentially targeting PD-1 regulation.

Indexed as

Killer Cells, NaturalProgrammed Cell Death 1 ReceptorRNA, Long NoncodingUp-RegulationGene Expression RegulationGene Knockdown TechniquesHumansPDCD1 protein, humanProgrammed Cell Death 1 ReceptorRNA, Long NoncodingCytokine stimulationFlow cytometryGene expressionImmune checkpointImmunotherapyLong non-coding RNA (lncRNA)Natural killer (NK) cellsPD-1RMRP

Identifiers

PMID41044334
PMCPMC12494946

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.